Please enable JavaScript to continue using this application.

Compare $ARDX vs $SANA | Chartloom

Compare

$ARDX vs $SANA

Ardelyx Inc · Sana Biotechnology Inc

ARDX

Ardelyx Inc

SANA

Sana Biotechnology Inc

Compare $ARDX vs $SANA

Comparing Ardelyx Inc and Sana Biotechnology Inc

ARDXArdelyx Inc

SANASana Biotechnology Inc

ARDXArdelyx Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

688.58x

Forward P/S (NTM)

1.51x

Rev growth (TTM)

16.8%

YTD performance

-46.7%

52W performance

-35.2%

FCF yield

-2.2%

SANASana Biotechnology Inc

Market cap

$776M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-33.4%

52W performance

-38.4%

FCF yield

-17.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARDX

SANA

Detailed metrics comparison

ARDX

Ardelyx Inc

SANA

Sana Biotechnology Inc

Market Cap

ARDX$810M

SANA$776M

Enterprise Value

ARDX$965M

SANA$719M

Price

ARDX$3.28

SANA$2.79

P/E Ratio

ARDXN/A

SANAN/A

P/S Ratio

ARDX1.80x

SANA0.00x

EV/Sales

ARDX2.14x

SANA0.00x

EV/EBITDA

ARDX454.80x

SANA0.00x

P/B Ratio

ARDX5.59x

SANA5.60x

P/FCF Ratio

ARDXN/A

SANAN/A

EV/FCF

ARDX-53.85x

SANA-5.33x

PEG Ratio

ARDXN/A

SANAN/A

Forward P/E (NTM)

ARDX688.58x

SANAN/A

Forward P/S (NTM)

ARDX1.51x

SANAN/A

Revenue (TTM)

ARDX$451M

SANA$0

Revenue Growth (YoY)

ARDX16.8%

SANAN/A

Forward Rev Growth

ARDX27.5%

SANA427.6%

Gross Margin (TTM)

ARDX94.4%

SANA0.0%

Operating Margin (TTM)

ARDX0.0%

SANA0.0%

EBITDA Margin (TTM)

ARDX-7.1%

SANA0.0%

Net Margin (TTM)

ARDX-12.4%

SANA0.0%

FCF Margin (TTM)

ARDX-4.0%

SANAN/A

Net Income (TTM)

ARDX$-56M

SANA$-212M

FCF (TTM)

ARDX$-18M

SANA$-135M

EPS (TTM)

ARDX-$0.22

SANA-$0.72

ROE (TTM)

ARDX-3600.0%

SANA-13449.0%

ROA (TTM)

ARDX-1077.0%

SANA-5112.0%

ROIC (TTM)

ARDX-1506.0%

SANA-13449.0%

Cash

ARDX$97M

SANA$57M

Debt

ARDX$252M

SANA$0

Net Cash/Debt

ARDX$-155M

SANA$57M

Current Ratio (TTM)

ARDX3.34x

SANA1.38x

Quick Ratio (TTM)

ARDX2.89x

SANA1.33x

Debt/Equity (TTM)

ARDX1.69x

SANA0.00x

Debt/Assets (TTM)

ARDX0.0%

SANA0.0%

Interest Coverage (TTM)

ARDXN/A

SANAN/A

Net Debt/EBITDA (TTM)

ARDX0.00x

SANA0.00x

Beta

ARDX0.72

SANA2.31

52W Performance

ARDX-35.2%

SANA-38.4%

YTD Performance

ARDX-46.7%

SANA-33.4%

% from 52W High

ARDX-61.0%

SANA-57.4%

% from 52W Low

ARDX3.1%

SANA6.9%

Asset Turnover (TTM)

ARDX0.87x

SANA0.00x

FCF Yield (TTM)

ARDX-2.2%

SANA-17.4%

Earnings Yield (TTM)

ARDX-6.9%

SANA-27.3%

Dividend Yield (TTM)

ARDXN/A

SANAN/A

Rule of 40

ARDX12.8

SANA0.0

EV/GP/RG

ARDX0.10

SANAN/A

Ticker research

View ARDX research View SANA research

Metric	ARDX Ardelyx Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$810M	$776M
Enterprise Value	$965M	$719M
Price	$3.28	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	1.80x	0.00x
EV/Sales	2.14x	0.00x
EV/EBITDA	454.80x	0.00x
P/B Ratio	5.59x	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-53.85x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	688.58x	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$451M	$0
Revenue Growth (YoY)	16.8%	N/A
Forward Rev Growth	27.5%	427.6%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.1%	0.0%
Net Margin (TTM)	-12.4%	0.0%
FCF Margin (TTM)	-4.0%	N/A
Net Income (TTM)	$-56M	$-212M
FCF (TTM)	$-18M	$-135M
EPS (TTM)	-$0.22	-$0.72
ROE (TTM)	-3600.0%	-13449.0%
ROA (TTM)	-1077.0%	-5112.0%
ROIC (TTM)	-1506.0%	-13449.0%
Financial Health
Cash	$97M	$57M
Debt	$252M	$0
Net Cash/Debt	$-155M	$57M
Current Ratio (TTM)	3.34x	1.38x
Quick Ratio (TTM)	2.89x	1.33x
Debt/Equity (TTM)	1.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	2.31
52W Performance	-35.2%	-38.4%
YTD Performance	-46.7%	-33.4%
% from 52W High	-61.0%	-57.4%
% from 52W Low	3.1%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-2.2%	-17.4%
Earnings Yield (TTM)	-6.9%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	12.8	0.0
EV/GP/RG	0.10	N/A
Ticker research	View ARDX research	View SANA research

Valuation

P/S Ratio

SANA

0.00x

ARDX

1.80x

EV/FCF

ARDX

-53.85x

SANA

-5.33x

Growth & revenue

Revenue Growth TTM

ARDX

16.8%

Forward Revenue Growth

SANA

427.6%

ARDX

27.5%

Profitability & performance

Gross Margin

ARDX

94.4%

SANA

0.0%

ROE

ARDX

-3600.0%

SANA

-13449.0%

FCF Yield %

ARDX

-2.2%

SANA

-17.4%

52-Week Performance

ARDX

-35.2%

SANA

-38.4%

Detailed metrics comparison

ARDX

Ardelyx Inc

SANA

Sana Biotechnology Inc

Market Cap

ARDX$810M

SANA$776M

Enterprise Value

ARDX$965M

SANA$719M

Price

ARDX$3.28

SANA$2.79

P/E Ratio

ARDXN/A

SANAN/A

P/S Ratio

ARDX1.80x

SANA0.00x

EV/Sales

ARDX2.14x

SANA0.00x

EV/EBITDA

ARDX454.80x

SANA0.00x

P/B Ratio

ARDX5.59x

SANA5.60x

P/FCF Ratio

ARDXN/A

SANAN/A

EV/FCF

ARDX-53.85x

SANA-5.33x

PEG Ratio

ARDXN/A

SANAN/A

Forward P/E (NTM)

ARDX688.58x

SANAN/A

Forward P/S (NTM)

ARDX1.51x

SANAN/A

Revenue (TTM)

ARDX$451M

SANA$0

Revenue Growth (YoY)

ARDX16.8%

SANAN/A

Forward Rev Growth

ARDX27.5%

SANA427.6%

Gross Margin (TTM)

ARDX94.4%

SANA0.0%

Operating Margin (TTM)

ARDX0.0%

SANA0.0%

EBITDA Margin (TTM)

ARDX-7.1%

SANA0.0%

Net Margin (TTM)

ARDX-12.4%

SANA0.0%

FCF Margin (TTM)

ARDX-4.0%

SANAN/A

Net Income (TTM)

ARDX$-56M

SANA$-212M

FCF (TTM)

ARDX$-18M

SANA$-135M

EPS (TTM)

ARDX-$0.22

SANA-$0.72

ROE (TTM)

ARDX-3600.0%

SANA-13449.0%

ROA (TTM)

ARDX-1077.0%

SANA-5112.0%

ROIC (TTM)

ARDX-1506.0%

SANA-13449.0%

Cash

ARDX$97M

SANA$57M

Debt

ARDX$252M

SANA$0

Net Cash/Debt

ARDX$-155M

SANA$57M

Current Ratio (TTM)

ARDX3.34x

SANA1.38x

Quick Ratio (TTM)

ARDX2.89x

SANA1.33x

Debt/Equity (TTM)

ARDX1.69x

SANA0.00x

Debt/Assets (TTM)

ARDX0.0%

SANA0.0%

Interest Coverage (TTM)

ARDXN/A

SANAN/A

Net Debt/EBITDA (TTM)

ARDX0.00x

SANA0.00x

Beta

ARDX0.72

SANA2.31

52W Performance

ARDX-35.2%

SANA-38.4%

YTD Performance

ARDX-46.7%

SANA-33.4%

% from 52W High

ARDX-61.0%

SANA-57.4%

% from 52W Low

ARDX3.1%

SANA6.9%

Asset Turnover (TTM)

ARDX0.87x

SANA0.00x

FCF Yield (TTM)

ARDX-2.2%

SANA-17.4%

Earnings Yield (TTM)

ARDX-6.9%

SANA-27.3%

Dividend Yield (TTM)

ARDXN/A

SANAN/A

Rule of 40

ARDX12.8

SANA0.0

EV/GP/RG

ARDX0.10

SANAN/A

Ticker research

View ARDX research View SANA research

Metric	ARDX Ardelyx Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$810M	$776M
Enterprise Value	$965M	$719M
Price	$3.28	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	1.80x	0.00x
EV/Sales	2.14x	0.00x
EV/EBITDA	454.80x	0.00x
P/B Ratio	5.59x	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-53.85x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	688.58x	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$451M	$0
Revenue Growth (YoY)	16.8%	N/A
Forward Rev Growth	27.5%	427.6%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.1%	0.0%
Net Margin (TTM)	-12.4%	0.0%
FCF Margin (TTM)	-4.0%	N/A
Net Income (TTM)	$-56M	$-212M
FCF (TTM)	$-18M	$-135M
EPS (TTM)	-$0.22	-$0.72
ROE (TTM)	-3600.0%	-13449.0%
ROA (TTM)	-1077.0%	-5112.0%
ROIC (TTM)	-1506.0%	-13449.0%
Financial Health
Cash	$97M	$57M
Debt	$252M	$0
Net Cash/Debt	$-155M	$57M
Current Ratio (TTM)	3.34x	1.38x
Quick Ratio (TTM)	2.89x	1.33x
Debt/Equity (TTM)	1.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	2.31
52W Performance	-35.2%	-38.4%
YTD Performance	-46.7%	-33.4%
% from 52W High	-61.0%	-57.4%
% from 52W Low	3.1%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-2.2%	-17.4%
Earnings Yield (TTM)	-6.9%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	12.8	0.0
EV/GP/RG	0.10	N/A
Ticker research	View ARDX research	View SANA research